Day One Biopharmaceuticals Inc (DAWN)
17.15
-0.42
(-2.39%)
USD |
NASDAQ |
May 03, 16:00
17.15
0.00 (0.00%)
After-Hours: 18:11
Day One Biopharmaceuticals Cash from Investing (TTM): 128.38M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 128.38M |
September 30, 2023 | 95.79M |
June 30, 2023 | -239.98M |
March 31, 2023 | -266.25M |
December 31, 2022 | -255.07M |
September 30, 2022 | -252.86M |
June 30, 2022 | -6.012M |
Date | Value |
---|---|
March 31, 2022 | -0.015M |
December 31, 2021 | -8.00M |
September 30, 2021 | -7.999M |
June 30, 2021 | -7.999M |
March 31, 2021 | -8.004M |
December 31, 2020 | -0.092M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-266.25M
Minimum
Mar 2023
128.38M
Maximum
Dec 2023
-63.70M
Average
-7.999M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Revolution Medicines Inc | -342.60M |
Zentalis Pharmaceuticals Inc | -44.46M |
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |
Xtant Medical Holdings Inc | -24.78M |